JAK1 and neoplasm: Mechanistically, METTL3 enhances the translation efficiency of Jak1 mRNA through m6A modification, thereby activating the JAK1-STAT3 signaling pathway and facilitating the formation of an immunosuppressive tumor microenvironment (Xiong et al., 2022).